The cellular protein p53 in human tumours

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• The p53 protein is a critical regulator of cell cycle and apoptosis.
• Alterations in p53 are frequently observed in various human cancers.
• Detecting p53 levels and associated antibodies can aid in cancer diagnosis and understanding.

Purpose of the Study:

• To quantify cellular p53 protein levels in colorectal and mammary tumours.
• To investigate the presence of anti-p53 antibodies in the sera of patients with these tumours.
• To examine the p53 gene's structure in tumour DNA.

Main Methods:

• Radioimmune assay (RIA) for cellular p53 quantification.
• RIA for detecting anti-p53 antibodies in patient sera.
• Southern blotting for analysing p53 gene arrangement in tumour DNA.

Main Results:

• Significantly increased p53 protein levels were detected in a substantial number of colorectal and mammary tumours compared to normal tissues.
• Anti-p53 antibodies were found in approximately 12% of the patients.
• Detectable p53 protein was also found in benign breast tumours (fibroadenomas), indicating its presence is not exclusive to malignancy.
• Southern blot analysis revealed no detectable alterations in the p53 gene arrangement in the tumours studied.

Conclusions:

• Elevated cellular p53 protein is a common finding in colorectal and mammary tumours, including benign ones.
• The p53 gene structure appears unaltered in these tumours despite increased protein levels.
• Further research is needed to understand the mechanisms leading to p53 accumulation and the role of anti-p53 antibodies in cancer.